RxDoctor Payments Data

Diane Rose, MD

Dermatology · Metairie, LANPI 1053302273

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 398 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations.

$9,050in general payments, 2019–2025

Across 398 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sanofi$1K
  • Merz North America, Inc.$571
  • Novartis$553
  • Pfizer$494
  • Johnson & Johnson$487
  • plus $5K from 29 others

What the payments were for

  • Food & beverage$8,79797%
  • Education$2533%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,050 in reported general payments places this provider in the 70th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana

Medicare billing

Part B allowed, 2024
$106,799
Medicare patients
278
Services billed
1,654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole191$2,130
Metronidazole33$1,734
Fluorouracil18$1,228
Doxycycline Hyclate45$1,190
ProgesteroneProgesterone, Micronized25$1,081
Triamcinolone Acetonide117$1,000
Imiquimod49$957
ValacyclovirValacyclovir Hcl37$951
Mometasone Furoate49$870
Betamethasone Dipropionate19$865
Ciclopirox25$757
Gentamicin Sulfate17$752
Clobetasol Propionate17$748
Minoxidil79$747
Nystatin32$377

Paid to pharmacies, not to this prescriber.

Other dermatology in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →